Skip to content

Rhomboid Intercostal and Subserratus / Paravertebral Block

Comparison of Rhomboid Intercostal and Subserratus Plane Blocks Applied for Postoperative Analgesia in Video-Assisted Thoracoscopic Surgery With Thoracic Paravertebral Block

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06253741
Enrollment
30
Registered
2024-02-12
Start date
2024-03-01
Completion date
2024-08-01
Last updated
2024-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Anesthesia, Thoracic

Brief summary

Postoperative pain is a significant concern following video-assisted thoracoscopic surgery (VATS). Pain after thoracic surgery not only causes a strong stress reaction and adverse emotional experience but also affects postoperative rehabilitation. Hence, different analgesia techniques, including local anesthetic infiltration, intercostal nerve block, paravertebral block, and thoracic epidural anesthesia, have been described to attenuate the intensity of acute postoperative painparavertebral block (PVB) and Rhomboid intercostal block with sub-serratus plane block (RISS) are the two types of plane blocks used for postoperative analgesia after video-assisted thoracoscopic surgery (VATS). This prospective randomized controlled trial was performed to analyze the postoperative analgesic effects of ultra- sound-guided PVB and RISS block after video-assisted thoracoscopic surgery.

Interventions

PROCEDUREPARAVERTEBRAL BLOCK

Hemodynamic data (mean arterial pressure, heart rate, oxygen saturation) will be recorded for all patients every 30 minutes during the intraoperative period, along with the amount of opioids used throughout the surgery. A patient-controlled analgesia device (PCA) will be connected to each patient 15 minutes before awakening, prepared with a 1mg/ml morphine solution, with a bolus dose of 2 ml and a lockout period of 15 minutes

Hemodynamic data (mean arterial pressure, heart rate, oxygen saturation) will be recorded for all patients every 30 minutes during the intraoperative period, along with the amount of opioids used throughout the surgery. A patient-controlled analgesia device (PCA) will be connected to each patient 15 minutes before awakening, prepared with a 1mg/ml morphine solution, with a bolus dose of 2 ml and a lockout period of 15 minutes.

PROCEDUREPLACEBO

Hemodynamic data (mean arterial pressure, heart rate, oxygen saturation) will be recorded for all patients every 30 minutes during the intraoperative period, along with the amount of opioids used throughout the surgery. A patient-controlled analgesia device (PCA) will be connected to each patient 15 minutes before awakening, prepared with a 1mg/ml morphine solution, with a bolus dose of 2 ml and a lockout period of 15 minutes.

Sponsors

Uludag University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Planned for VATS * American Society of Anesthesiologists (ASA) class I and II * Patients aged between 18-80

Exclusion criteria

* Contraindications to local anesthetic allergy or bupivacaine * Known or suspected coagulopathy * Injection site infection * History of thoracic surgery * Severe neurological or psychiatric disorder * Severe cardiovascular disease * Liver failure * Renal failure (glomerular filtration rate \<15 ml/min/1.73 m2) * Chronic opioid use

Design outcomes

Primary

MeasureTime frameDescription
VAS scoresup to 24 hoursThe primary outcome of this study was to compare the analgesia of paravertebral block versus rhomboid intercostal and subserratus plane block in VATS surgery.

Secondary

MeasureTime frameDescription
morphine consumptionup to 24 hoursThe secondary outcome measure in this study was 24-hour morphine consumption.
first analgesia requirementup to 24 hoursSecondary outcome measures included time to first request for morphine
Side effectsup to 24 hoursSide effects associated with morphine consumption

Countries

Turkey (Türkiye)

Contacts

Primary ContactSEDA CANSABUNCU
sedacansabuncu@uludag.edu.tr+9002242940000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026